Kestra Advisory Services’s Checkpoint Therapeutics CKPT Stock Holding History

Kestra Advisory Services’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-165,400	Closed	-$668K	–	2845
2025 Q1	$668K	Sell	165,400 -163,881	-50%	-$546K	﹤0.01%	1637
2024 Q4	$1.05M	Buy	+329,281	New	+$1.12M	0.01%	1385

Kestra Advisory Services's CKPT Position: Q2 2025 in Review

Kestra Advisory Services sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 165,400 shares — an estimated $668K sold.

Kestra Advisory Services first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $1.05M in Q4 2024. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Kestra Advisory Services reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Kestra Advisory Services sold 165,400 Checkpoint Therapeutics shares in Q2 2025, an estimated $668K.
Kestra Advisory Services first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
Kestra Advisory Services's Checkpoint Therapeutics position peaked at $1.05M in Q4 2024.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Kestra Advisory Services's 13F filing for Q2 2025, filed 15 Aug 2025.